243 related articles for article (PubMed ID: 18316585)
1. Targeted delivery of small interfering RNA: approaching effective cancer therapies.
Pirollo KF; Chang EH
Cancer Res; 2008 Mar; 68(5):1247-50. PubMed ID: 18316585
[TBL] [Abstract][Full Text] [Related]
2. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
Pirollo KF; Rait A; Zhou Q; Hwang SH; Dagata JA; Zon G; Hogrefe RI; Palchik G; Chang EH
Cancer Res; 2007 Apr; 67(7):2938-43. PubMed ID: 17409398
[TBL] [Abstract][Full Text] [Related]
3. Advances in cancer gene therapy: tumor-targeted delivery of therapeutic pDNA, siRNA, and dsRNA nucleic acids.
Wagner E
J BUON; 2007 Sep; 12 Suppl 1():S77-82. PubMed ID: 17935282
[TBL] [Abstract][Full Text] [Related]
4. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
Liu B
Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766
[TBL] [Abstract][Full Text] [Related]
5. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
[TBL] [Abstract][Full Text] [Related]
6. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
[TBL] [Abstract][Full Text] [Related]
7. siRNA-mediated antitumorigenesis for drug target validation and therapeutics.
Lu PY; Xie FY; Woodle MC
Curr Opin Mol Ther; 2003 Jun; 5(3):225-34. PubMed ID: 12870431
[TBL] [Abstract][Full Text] [Related]
8. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
9. RNA interference for the treatment of cancer.
Putral LN; Gu W; McMillan NA
Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967
[TBL] [Abstract][Full Text] [Related]
10. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
11. A nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo.
Yagi N; Manabe I; Tottori T; Ishihara A; Ogata F; Kim JH; Nishimura S; Fujiu K; Oishi Y; Itaka K; Kato Y; Yamauchi M; Nagai R
Cancer Res; 2009 Aug; 69(16):6531-8. PubMed ID: 19654315
[TBL] [Abstract][Full Text] [Related]
12. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters).
Vandenbroucke RE; De Geest BG; Bonné S; Vinken M; Van Haecke T; Heimberg H; Wagner E; Rogiers V; De Smedt SC; Demeester J; Sanders NN
J Gene Med; 2008 Jul; 10(7):783-94. PubMed ID: 18470950
[TBL] [Abstract][Full Text] [Related]
13. Targeted quantum dot conjugates for siRNA delivery.
Derfus AM; Chen AA; Min DH; Ruoslahti E; Bhatia SN
Bioconjug Chem; 2007; 18(5):1391-6. PubMed ID: 17630789
[TBL] [Abstract][Full Text] [Related]
14. A review of nanocarriers for the delivery of small interfering RNA.
Kesharwani P; Gajbhiye V; Jain NK
Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
[TBL] [Abstract][Full Text] [Related]
15. Advances in the development of siRNA-based therapeutics for cancer.
Shen Y
IDrugs; 2008 Aug; 11(8):572-8. PubMed ID: 18683092
[TBL] [Abstract][Full Text] [Related]
16. Bioreducible polymers for efficient gene and siRNA delivery.
Jere D; Arote R; Jiang HL; Kim YK; Cho MH; Cho CS
Biomed Mater; 2009 Apr; 4(2):025020. PubMed ID: 19349651
[TBL] [Abstract][Full Text] [Related]
17. Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors.
García-Castro J; Martínez-Palacio J; Lillo R; García-Sánchez F; Alemany R; Madero L; Bueren JA; Ramírez M
Cancer Gene Ther; 2005 Apr; 12(4):341-9. PubMed ID: 15650763
[TBL] [Abstract][Full Text] [Related]
18. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
[TBL] [Abstract][Full Text] [Related]
19. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
[TBL] [Abstract][Full Text] [Related]
20. Cancer, chitosan nanoparticles and catalytic nucleic acids.
Tan ML; Choong PF; Dass CR
J Pharm Pharmacol; 2009 Jan; 61(1):3-12. PubMed ID: 19126291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]